QURE
QURE
NASDAQ · Biotechnology

Uniqure Nv

$43.63
+1.44 (+3.41%)
As of Aug 8, 1:39 AM ET ·
Financial Highlights (FY 2026)
Revenue
20.19M
Net Income
-249,538,925
Gross Margin
89.5%
Profit Margin
-1,236.0%
Rev Growth
-46.7%
D/E Ratio
2.63
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 89.5% 89.5% 45.0% 45.0%
Operating Margin -1,151.4% -1,036.2% 12.4% 10.9%
Profit Margin -1,236.0% -1,174.2% 12.0% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 20.19M 37.91M 366.27M 316.03M
Gross Profit 18.08M 33.94M 164.91M 142.29M
Operating Income -232,495,100 -392,801,933 45.48M 34.44M
Net Income -249,538,925 -421,597,583 43.81M 38.10M
Gross Margin 89.5% 89.5% 45.0% 45.0%
Operating Margin -1,151.4% -1,036.2% 12.4% 10.9%
Profit Margin -1,236.0% -1,174.2% 12.0% 12.1%
Rev Growth -46.7% -46.7% -4.9% -4.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.14B 1.14B 204.81M 207.31M
Total Equity 433.53M 433.53M 806.10M 940.40M
D/E Ratio 2.63 2.63 0.25 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -213,949,231 -381,550,158 53.48M 50.33M
Free Cash Flow 19.66M 18.73M